Lacy Russell, APRN
Family · Salyersville, KYNPI 1275001869
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 35.9% of the total. 2025 is the largest year on record at $292, 8.4 times the $35 reported in 2022. That places this record below the midpoint for family clinicians in KY, where the typical reported total is $464.
Across 26 payments — averaging $14.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$137
- Amgen$76
- AbbVie$50
- Sanofi$40
- Indivior Inc.$38
- Novo Nordisk$15
- plus $25 from 2 others
What the payments were for
- Food & beverage$381100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $137 |
| Amgen | 4 | $76 |
| AbbVie | 2 | $50 |
| Sanofi | 1 | $40 |
| Indivior Inc. | 2 | $38 |
| Novo Nordisk | 1 | $15 |
| Alkermes, Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$381 in reported general payments places this provider in the 45th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $16,760 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $13,529 |
| EliquisApixaban | 11 | $13,230 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $12,024 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 180 | $11,942 |
| XareltoRivaroxaban | 12 | $11,143 |
| VascepaIcosapent Ethyl | 12 | $4,185 |
| Ventolin HfaAlbuterol Sulfate | 32 | $3,232 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,134 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 70 | $2,535 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $2,136 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,802 |
| Prednisone | 164 | $1,741 |
| Esomeprazole Magnesium | 29 | $1,326 |
| Ondansetron OdtOndansetron | 35 | $1,038 |
Paid to pharmacies, not to this prescriber.
Other family in Salyersville
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
- Carrie Parrish NyekanBowling Green$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.